arrow
L

Laurent A. Décosterd

University of Geneva
H指数:56
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study

顺铂和nab-紫杉醇加压腹腔内气溶胶化疗(PIPAC)在腹膜癌病患者的安全性和有效性:Nab-PIPAC 1b期研究

2026-09-010
OAAI
Ruxolitinib Pharmacokinetics and Exposure–Toxicity Relationship in Hematologic Malignancies and Immune‐Mediated Diseases: A Prospective Observational Study

鲁索利替尼在血液恶性肿瘤和免疫介导性疾病中的药代动力学及暴露-毒性关系:一项前瞻性观察研究

2026-06-240
OAAI
Sorafenib plus selective internal radiotherapy with 90Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial

索拉非尼联合选择性内部放射治疗(使用90Y树脂微球)治疗眼脉络膜黑色素瘤肝转移:一项I期临床试验

2025-12-110
OAAI
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO

左西孟旦及其代谢物OR-1855和OR-1896在危重成人、新生儿和婴儿经静脉-动脉ECMO治疗中的群体药代动力学

2025-11-250
OAAI
A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring

一种用于血浆中囊性纤维化药物(Caftors)定量分析的液相色谱-串联质谱法及其在治疗监测中的应用

2025-04-220
OA
Highly sensitive ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method for the multiplex analysis of levosimendan and its metabolites OR-1855 and OR-1896 in human plasma
2025-03-010
PRE
Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study

腹腔脓肿中抗菌及抗真菌药物的浓度:一项前瞻性临床研究

2025-01-310
PRE
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial
2024-10-160
OAAI
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
2024-09-024
PRE
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV
2024-03-222
OAAI